Relative Oral Bioavailability of an Abuse-Deterrent, Extended-Release Formulation of Morphine Versus Extended-Release Morphine: A 2-Period, Single-Dose, Randomized Crossover Study in Healthy Subjects
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2018.06.010
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2018
Authors
Publisher
Elsevier BV